Titre:
  • A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
Auteur:ten Bokkel Huinink, Wim; Prove, A M; Piccart-Gebhart, Martine; Steward, W; Tursz, T; Wanders, Jantien; Franklin, H; Clavel, Michel; Verweij, Jaap; Alakl, M
Informations sur la publication:Annals of oncology, 5, 6, page (527-532)
Statut de publication:Publié, 1994-07
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast cancer
Docetaxel
MeSH keywords:Adult
Aged
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Agents, Phytogenic -- adverse effects
Antineoplastic Agents, Phytogenic -- therapeutic use
Breast Neoplasms -- drug therapy
Drug Administration Schedule
Drug Eruptions -- etiology
Europe
Female
Humans
Middle Aged
Nervous System Diseases -- chemically induced
Neutropenia -- chemically induced
Paclitaxel -- administration & dosage
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Paclitaxel -- therapeutic use
Remission Induction
Taxoids
Note générale:Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:scp/0028260937
info:pmid/7918124